ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IKT Inhibikase Therapeutics Inc

1.84
0.03 (1.66%)
May 31 2024 - Closed
Delayed by 15 minutes

Inhibikase Therapeutics Financial Summary

The current IKT market cap is 11.36M. The company's latest EPS is USD -3.0820 and P/E is -0.61.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 63k65k116k80k0
Operating Income -4.34M-4.72M-6.2M-4.77M-4.4M
Net Income -4.28M-4.48M-5.78M-4.6M-4.18M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.12M698k3.1M123k261k
Operating Income -5.7M-2.82M-14.77M-18.13M-20.09M
Net Income -5.72M-2.85M-14.79M-18.05M-19.03M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 24.94M28.16M22.35M17.88M14.51M
Total Liabilities 3.9M2.84M2.88M2.86M3.53M
Total Equity 21.04M25.32M19.46M15.02M10.98M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 38k14.78M42.47M24.94M14.51M
Total Liabilities 4.53M5M4.05M3.9M3.53M
Total Equity -4.49M9.78M38.42M21.04M10.98M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -17.35M-5.97M-10.54M-14.64M-18.09M
Investing -16.01M-5.84M-3.29M13.77M11.66M
Financing -205k8.58M8.54M8.54M8.41M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -338k-1.13M-14.3M-17.35M-18.09M
Investing N/A N/A N/A -16.01M11.66M
Financing -23k15.07M41.09M-205k8.41M
Market Cap 11.36M
Price to Earnings Ratio -0.61
Price to Sales Ratio 44.68
Price to Cash Ratio 1.27
Price to Book Ratio 1.06
Dividend Yield -

Share Statistics

Shares Outstanding 6.17M
Average Volume (1 week) 21.88k
Average Volume (1 Month) 71.1k
52 Week Change -52.71%
52 Week High 4.3512
52 Week Low 0.79
Spread (Intraday) 0.19 (9.55%)

Company Info

Company Name Inhibikase Therapeutics Inc
Address 1313 n market st ste 5100
wilmington, delaware 19801
Website https://www.inhibikase.com
Industry biological pds,ex diagnstics (2836)